FRONTEO Inc. (Headquarters: Minato-ku, Tokyo, President: Masahiro Morimoto, hereafter FRONTEO) collaborates with Amazon Web Services Japan GK (hereafter AWS Japan) to provide the cloud platform "Amazon" provided by Amazon Web Services. We are pleased to announce that we will start development for the development of AI medical devices and healthcare solutions on "Web Services" (hereinafter referred to as "AWS").

 

　FRONTEO is working on the development of AI medical devices and healthcare solutions that utilize the proprietary natural language processing AI engine "Concept Encoder (trademark: conceptencoder, reading: concept encoder)".Through this collaboration, it is expected that these products will be able to be stably distributed and distributed to medical institutions nationwide while ensuring a high level of security.

 

　FRONTEO will contribute to improving the quality and efficiency of medical care, as well as improving patient health and QOL, through research and development of high-quality AI medical equipment and healthcare solutions and provision to medical sites.

 

■ About FRONTEO　URL:https://www.fronteo.com/
FRONTEO uses the in-house developed AI engines "KIBIT", "Concept Encoder", and "Looca Cross" that specialize in natural language processing to extract meaningful and important information from a huge amount of text data, and is a company. It is a data analysis company that supports the business of. Since its establishment in August 2003, it has been expanding globally to Japan, the United States, South Korea, and Taiwan, focusing on legal tech businesses such as "e-discovery (electronic discovery)" and "digital forensic investigation" that support corporate international litigation. Has been deployed.Based on the AI ​​technology cultivated in this business, we will expand the business field to the life science field, business intelligence field, and economic security from 8, and by using AI to "turn text data into knowledge", We contribute to solving various corporate issues such as drug discovery support, dementia diagnosis support, financial, personnel, and sales support. Listed on TSE Mothers on June 2014, 2007. Obtained a first-class medical device manufacturing and sales business license in January 6 (permit number: 26B2021X1), and notified the managed medical device sales business in September of the same year (notification number: 13 Minato Misei Equipment No. 1).The capital is 10350 thousand yen (as of March 9, 3).

■ About Concept Encoder　URL:https://lifescience.fronteo.com/technology/conceptencoder/
"Concept Encoder" is a natural language analysis AI (artificial intelligence) developed by FRONTEO specially in the life science field.It was developed in 2018 with the aim of effectively analyzing and utilizing medical data containing a large amount of free-form text data based on evidence. Concept Encoder can be co-analyzed with data other than text, and we are conducting research on co-analysis with numerical data such as gene expression information, vitals, and various test values ​​accumulated in the life science field.Patent registration number: Patent No. 6346367

* FRONTEO, conceptencoder, and KIBIT are registered trademarks of FRONTEO in Japan.